Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCR8 | P51685 | 1/20 | 0.48 |
| ▸ | S1PR5 | Q9H228 | 9/20 | 0.48 |
| ▸ | S1PR1 | P21453 | 2/20 | 0.46 |
| ▸ | S1PR3 | Q99500 | 2/20 | 0.46 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.45 |
| ▸ | GAA | P10253 | 1/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.44 |
| ▸ | DRD2 | P14416 | 2/20 | 0.43 |
| ▸ | DRD4 | P21917 | 2/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL34460295 | 0.92 | S1PR5 (0.46) | S1PR5S1PR1S1PR3SIGMAR1ALDH1A1 | |
| SCHEMBL31236031 | 0.92 | S1PR5 (0.46) | S1PR5S1PR1S1PR3SIGMAR1ALDH1A1 | |
| SCHEMBL25344327 | 0.88 | S1PR5 (0.51) | S1PR5S1PR1S1PR3SIGMAR1ALDH1A1 | |
| SCHEMBL31236079 | 0.86 | SIGMAR1 (0.47) | S1PR5S1PR1S1PR3SIGMAR1ALDH1A1 | |
| SCHEMBL25342485 | 0.85 | S1PR5 (0.49) | S1PR5S1PR1S1PR3SIGMAR1ALDH1A1 | |
| SCHEMBL31024716 | 0.85 | S1PR5 (0.49) | S1PR5S1PR1S1PR3SIGMAR1ALDH1A1 | |
| SCHEMBL31380547 | 0.82 | S1PR5 (0.46) | S1PR5S1PR1S1PR3SIGMAR1ALDH1A1 | |
| SCHEMBL31236014 | 0.81 | CRBN (0.49) | DRD2DRD4 | |
| SCHEMBL26134138 | 0.81 | S1PR5 (0.47) | S1PR5S1PR1S1PR3SIGMAR1ALDH1A1 | |
| SCHEMBL320767 | 0.79 | SIGMAR1 (0.63) | S1PR5S1PR1S1PR3SIGMAR1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4722219-A1 | CEREBELLAR PROTEIN E3 UBIQUITIN LIGASE INHIBITOR AND CHIMERIC COMPOUND TARGETING PROTEIN DEGRADATION | Gan & Lee Pharmaceuticals Co., Ltd. (CN) | 2026-04-08 | — | — | EP | disclosed |
| WO-2024240268-A1 | CEREBELLAR PROTEIN E3 UBIQUITIN LIGASE INHIBITOR AND CHIMERIC COMPOUND TARGETING PROTEIN DEGRADATION | 甘李药业股份有限公司 | 2024-11-28 | — | — | WO | disclosed |